|
|
| (One intermediate revision by the same user not shown) |
| Line 242: |
Line 242: |
|
| |
|
| ===Situations where prostate adenocarcinoma may be missed=== | | ===Situations where prostate adenocarcinoma may be missed=== |
| Key reasons for false negative prostate samples<ref>{{cite journal |vauthors=Yang C, Humphrey PA |title=False-Negative Histopathologic Diagnosis of Prostatic Adenocarcinoma |journal=Arch. Pathol. Lab. Med. |volume=144 |issue=3 |pages=326–334 |date=March 2020 |pmid=31729886 |doi=10.5858/arpa.2019-0456-RA |url=}}</ref>: | | Key reasons for false negative prostate samples<ref>{{cite journal |authors=Yang C, Humphrey PA |title=False-Negative Histopathologic Diagnosis of Prostatic Adenocarcinoma |journal=Arch. Pathol. Lab. Med. |volume=144 |issue=3 |pages=326–334 |date=March 2020 |pmid=31729886 |doi=10.5858/arpa.2019-0456-RA |url=}}</ref>: |
| *Tissue artefacts (try levels and/or IHC): | | *Tissue artefacts (try levels and/or IHC): |
| **Crush artefact | | **Crush artefact |
| Line 691: |
Line 691: |
|
| |
|
| ==Prostatic signet ring cell carcinoma== | | ==Prostatic signet ring cell carcinoma== |
| {{Main|Signet ring cell carcinoma}} | | {{Main|Prostatic signet ring cell carcinoma}} |
| ===General===
| |
| *Very rare - 9 cases in a series of 29,783 prostate cancer cases.<ref name=pmid21123640>{{Cite journal | last1 = Warner | first1 = JN. | last2 = Nakamura | first2 = LY. | last3 = Pacelli | first3 = A. | last4 = Humphreys | first4 = MR. | last5 = Castle | first5 = EP. | title = Primary signet ring cell carcinoma of the prostate. | journal = Mayo Clin Proc | volume = 85 | issue = 12 | pages = 1130-6 | month = Dec | year = 2010 | doi = 10.4065/mcp.2010.0463 | PMID = 21123640 }}</ref>
| |
| *Criteria vary - percentage of SRCs required for Dx varies from 20% to 50%.<ref name=pmid21123640/>
| |
| | |
| ===Microscopic===
| |
| Features:
| |
| *Signet ring cells - see ''[[basics]]'' article.
| |
| | |
| DDx:
| |
| *Acinar adenocarcinoma - Gleason pattern 4 with very small glands.
| |
| | |
| ====Images====
| |
| *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996149/figure/F1/ Prostatic SRCC (nih.gov)].
| |
| *[http://www.nature.com/modpathol/journal/v17/n3/fig_tab/3800052f7.html#figure-title Prostatic SRCC (nature.com)].
| |
| *[http://www.nature.com/modpathol/journal/v17/n3/fig_tab/3800052f8.html Prostatic SRCC (nature.com)].
| |
| *[http://www.webpathology.com/image.asp?case=23&n=34 Prostatic SRCC (webpathology.com)] - looks like ''acinar adenocarcinoma''.
| |
| | |
| ===Stains===
| |
| *Alcian blue-PAS stain +ve.
| |
| *[[PAS stain|PAS]] -- 50% of cases +ve.<ref name=pmid21123640/>
| |
| *[[Alcian blue stain|Alcian blue]] -- 44% of cases +ve.<ref name=pmid21123640/>
| |
|
| |
|
| ==Sarcomatoid carcinoma of the prostate== | | ==Sarcomatoid carcinoma of the prostate== |